247 related articles for article (PubMed ID: 9827969)
1. Comparison of multiple immunization schedules for Haemophilus influenzae type b-conjugate and tetanus toxoid vaccines following bone marrow transplantation.
Vance E; George S; Guinan EC; Wheeler C; Antin JH; Ambrosino DM; Molrine DC
Bone Marrow Transplant; 1998 Oct; 22(8):735-41. PubMed ID: 9827969
[TBL] [Abstract][Full Text] [Related]
2. Antibody responses to tetanus toxoid and Haemophilus influenzae type b conjugate vaccines following autologous peripheral blood stem cell transplantation (PBSCT).
Chan CY; Molrine DC; Antin JH; Wheeler C; Guinan EC; Weinstein HJ; Phillips NR; McGarigle C; Harvey S; Schnipper C; Ambrosino DM
Bone Marrow Transplant; 1997 Jul; 20(1):33-8. PubMed ID: 9232253
[TBL] [Abstract][Full Text] [Related]
3. Haemophilus influenzae type b (HIB)-conjugate immunization before bone marrow harvest in autologous bone marrow transplantation.
Molrine DC; Guinan EC; Antin JH; Wheeler C; Parsons SK; Weinstein HJ; McGarigle C; Blanding P; Phillips NR; Ciamarra A; George S; Ambrosino DM
Bone Marrow Transplant; 1996 Jun; 17(6):1149-55. PubMed ID: 8807128
[TBL] [Abstract][Full Text] [Related]
4. Dose response of CRM197 and tetanus toxoid-conjugated Haemophilus influenzae type b vaccines.
Huebner RE; Nicol M; Mothupi R; Käyhty H; Mbelle N; Khomo E; Klugman KP
Vaccine; 2004 Dec; 23(6):802-6. PubMed ID: 15542205
[TBL] [Abstract][Full Text] [Related]
5. A comparison of early and late vaccination with Haemophilus influenzae type b conjugate and pneumococcal polysaccharide vaccines after allogeneic BMT.
Parkkali T; Käyhty H; Ruutu T; Volin L; Eskola J; Ruutu P
Bone Marrow Transplant; 1996 Nov; 18(5):961-7. PubMed ID: 8932852
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.
Punjabi NH; Richie EL; Simanjuntak CH; Harjanto SJ; Wangsasaputra F; Arjoso S; Rofiq A; Prijanto M; Julitasari ; Yela U; Herzog C; Cryz SJ
Vaccine; 2006 Mar; 24(11):1776-85. PubMed ID: 16303216
[TBL] [Abstract][Full Text] [Related]
7. Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children.
Lehmann D; Kakazo M; Saleu G; Taime J; Javati A; Namuigi P; Alpers MP; Wegmüller B; Zellmeyer M; Fürer E; Que JU; Herzog C
P N G Med J; 2001; 44(1-2):6-16. PubMed ID: 12418673
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine.
Panpitpat C; Thisyakorn U; Chotpitayasunondh T; Fürer E; Que JU; Hasler T; Cryz SJ
Bull World Health Organ; 2000; 78(3):364-71. PubMed ID: 10812736
[TBL] [Abstract][Full Text] [Related]
9. Effect of transplacentally acquired tetanus antibodies on the antibody responses to Haemophilus influenzae type b-tetanus toxoid conjugate and tetanus toxoid vaccines in Filipino infants.
Nohynek H; Gustafsson L; Capeding MR; Käyhty H; Olander RM; Pascualk L; Ruutu P
Pediatr Infect Dis J; 1999 Jan; 18(1):25-30. PubMed ID: 9951976
[TBL] [Abstract][Full Text] [Related]
10. Primary vaccination of infants with diphtheria-tetanus-acellular pertussis-hepatitis B virus- inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections.
Schmitt HJ; Knuf M; Ortiz E; Sänger R; Uwamwezi MC; Kaufhold A
J Pediatr; 2000 Sep; 137(3):304-12. PubMed ID: 10969252
[TBL] [Abstract][Full Text] [Related]
11. Safety and immunogenicity of Haemophilus influenzae type B vaccine given in combination with DTwP at 6, 10 and 14 weeks of age.
Cherian T; Thomas N; Raghupathy P; Durot I; Dutta A
Indian Pediatr; 2002 May; 39(5):427-36. PubMed ID: 12037271
[TBL] [Abstract][Full Text] [Related]
12. A randomized comparison between early and late vaccination with tetanus toxoid vaccine after allogeneic BMT.
Parkkali T; Olander RM; Ruutu T; Vuontela K; Volin L; Eskola J; Ruutu P
Bone Marrow Transplant; 1997 May; 19(9):933-8. PubMed ID: 9156269
[TBL] [Abstract][Full Text] [Related]
13. IgG subclasses and avidity of antibodies to polysaccharide antigens in allogeneic BMT recipients after vaccination with pneumococcal polysaccharide and Haemophilus influenzae type b conjugate vaccines.
Parkkali T; Käyhty H; Anttila M; Ruutu T; Wuorimaa T; Soininen A; Volin L; Ruutu P
Bone Marrow Transplant; 1999 Sep; 24(6):671-8. PubMed ID: 10490735
[TBL] [Abstract][Full Text] [Related]
14. Suppression and modulation of cellular and humoral immune responses to Haemophilus influenzae type B (Hib) conjugate vaccine in hib-diphtheria-tetanus toxoids-acellular pertussis combination vaccines: a study in a rat model.
Mawas F; Newman G; Burns S; Corbel MJ
J Infect Dis; 2005 Jan; 191(1):58-64. PubMed ID: 15593004
[TBL] [Abstract][Full Text] [Related]
15. Maternal immunization with Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in The Gambia.
Mulholland K; Suara RO; Siber G; Roberton D; Jaffar S; N'Jie J; Baden L; Thompson C; Anwaruddin R; Dinan L; Glezen WP; Francis N; Fritzell B; Greenwood BM
JAMA; 1996 Apr; 275(15):1182-8. PubMed ID: 8609686
[TBL] [Abstract][Full Text] [Related]
16. Antibodies against Haemophilus influenzae type b capsular polysaccharide and tetanus toxoid before and after a booster dose of the carrier protein nine years after primary vaccination with a protein conjugate vaccine.
Claesson BA; Trollfors B; Lagergård T; Knutsson N; Schneerson R; Robbins JB
Pediatr Infect Dis J; 2005 May; 24(5):463-4. PubMed ID: 15876951
[TBL] [Abstract][Full Text] [Related]
17. Avidity maturation of antibody to Haemophilus influenzae type b (Hib) after immunization with diphtheria-tetanus-acellular pertussis-hib-hepatitis B combined vaccine in infants.
Pichichero ME; Voloshen T; Zajac D; Passador S
J Infect Dis; 1999 Oct; 180(4):1390-3. PubMed ID: 10479180
[TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity of haemophilus influenzae type B polysaccharide or conjugate vaccines in an elderly adult population.
Lottenbach KR; Granoff DM; Barenkamp SJ; Powers DC; Kennedy D; Irby-Moore S; Homan SM; Mink CM
J Am Geriatr Soc; 2004 Nov; 52(11):1883-7. PubMed ID: 15507066
[TBL] [Abstract][Full Text] [Related]
19. Decreased point prevalence of Haemophilus influenzae type b (Hib) oropharyngeal colonization by mass immunization of Brazilian children less than 5 years old with hib polyribosylribitol phosphate polysaccharide-tetanus toxoid conjugate vaccine in combination with diphtheria-tetanus toxoids-pertussis vaccine.
Forleo-Neto E; de Oliveira CF; Maluf EM; Bataglin C; Araujo JM; Kunz LF; Pustai AK; Vieira VS; Zanella RC; Brandileone MC; Mimica LM; Mimica IM
J Infect Dis; 1999 Oct; 180(4):1153-8. PubMed ID: 10479142
[TBL] [Abstract][Full Text] [Related]
20. Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster.
Booy R; Heath PT; Slack MP; Begg N; Moxon ER
Lancet; 1997 Apr; 349(9060):1197-202. PubMed ID: 9130940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
